Developed to treat erectile dysfunction, AR1001 slowed Alzheimer’s decline by 31 percent in one specific group. Researchers ...
Maybe being bone-headed is a good thing. With over 900,000 people getting diagnosed with Alzheimer’s every year in the US, ...
Mirodenafil (known as AR1001), an oral phosphodiesterase-5 inhibitor approved in South Korea to treat erectile dysfunction, ...
Some research suggests a cardio workout beloved by millions of American men may be interfering with their sexual function — ...
"Will things go well until the end today?"As night approached, I spent all my timethinking about things like that.Hello, I'm ...
Dicot Pharma has now initiated the clinical phase 2b study of the drug candidate LIB-01, which is being developed as a novel treatment for erectile dysfunction. The study has formally started ...
New clinical research demonstrates that male infertility and erectile dysfunction share fundamental endocrine, metabolic, and ...
Erectile dysfunction (ED), or difficulty getting or maintaining an erection firm enough for sex, becomes more common with age ...
From brain gene-editing attempt gone wrong to high-speed torpedo tech, here are some highlights from SCMP's recent science ...
Erectile dysfunction treatment should therefore begin with understanding the underlying cause rather than immediately selecting medication.
Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. Urologist John Smith, DO, addresses the barriers to honest conversation about ED, ...
Dicot Pharma AB has now initiated the clinical phase 2b study of the drug candidate LIB-01, which is being developed as a ...